FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Locust Walk Acquisition Corp. Shares Skyrocket Upon Merger Approval ”
Locust Walk Acquisition Corp. (NASDAQ: LWAC) surged 150% in premarket trading after the company’s stockholders approved all proposals related to the previously announced business combination with eFFECTOR Therapeutics, Inc.
The Business Combination is expected to close today, August 25th, and upon closing, the combined company expects that its common stock and public warrants will commence trading on Nasdaq under the new trading symbols “EFTR” and “EFTRW,” respectively, the following day.
Locust Walk Acquisition Corp. (NASDAQ: LWAC) is a blank-check company formed for the purpose of entering a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities.
For more information, please visit: Locust Walk Acquisition Corp.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.
The post “The Buzz” Show: Locust Walk Acquisition Corp. (NASDAQ: LWAC) Merger Approval first appeared on Financial Buzz .
For further details see:
“The Buzz” Show: Locust Walk Acquisition Corp. (NASDAQ: LWAC) Merger Approval